The Vitiligo Market continues to expand at a significant pace as global demand for effective depigmentation disorder therapies rises steadily amid growing disease awareness and expanding treatment pipelines. Vitiligo, an autoimmune condition characterized by the progressive loss of melanocytes resulting in patchy depigmentation, affects approximately 1-2% of the global population across all...